Axantia was established in 2014 to build a robust and differentiated, branded generics, Emerging Markets company. Axantia is committed to delivering high quality, innovative bio-pharmaceutical products to patients, payers, and caregivers. Axantia has a presence in over 20 countries across Africa, the Middle East and the CIS.
Ready for a personalized experience? We use cookies and similar technologies to tailor our site just for you. By clicking 'Accept', you're giving us the thumbs up to use cookies and similar technologies. 🍪
